Dr Reddy’s launch Lansoprazole DR orally disintegrating tablets

They are indicated for the treatment of duodenal ulcers, gastric ulcers, GERD, erosive esophagitis and pathological hypersecretory syndromes.

40
Medicine Tablets
Picture: Unsolash

Dr Reddy’s Laboratories announced the launch of Lansoprazole DR orally disintegrating tablets, a therapeutic equivalent generic version of Prevacid SoluTab Delayed-Release Orally Disintegrating Tablets, 15 mg and 30 mg, approved by the US Food and Drug Administration (USFDA).

Prevacid is a trademark of Takeda Pharmaceuticals USA.

They are indicated for the treatment of duodenal ulcers, gastric ulcers, GERD, erosive esophagitis and pathological hypersecretory syndromes.

The Prevacid brand and generic had US sales of approximately $87 million MAT for the most recent twelve months ending in December 2020 according to IMS Health*.

Dr Reddy’s Lansoprazole DR Orally Disintegrating Tablets are available in 15 mg and 30 mg tablets in unit-dose packages of 100 (10 x 10).


Also read:

Unichem gets USFDA approval for Apremilast Tablets

Lupin gets USFDA nod to market generic Droxidopa capsules

Aurobindo Pharma gets USFDA nod for generic Droxidopa capsules

Zydus Cadila gets USFDA nod for low Blood Pressure drug


The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.

Go to main website, click here

Follow and connect with us on Facebook and Linkedin

Subscribe for daily free updates, click here

For daily free updates on WhatsApp, click here

Subscribe here for daily updates
Loading

LEAVE A REPLY

Please enter your comment!
Please enter your name here